ClinicalTrials.gg
RecruitingNCT07135843iPATHUpdated Sep 2, 2025

Digital Home-Based Physical Activity Promotion for Older Adults After Total Hip Arthroplasty

An interventional study of Digital exercise program and Personal coaching for physical activity promotion in Total Hip Arthroplasty (THA) and Older Adults (65 Years and Older), sponsored by Heidelberg University. Recruiting at 1 site in Germany. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2025-09-02.

Sponsored by Heidelberg University · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
213
Allocation
Randomized
Ages
65 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 223 studies in Motor Activity with a site in Germany — 41 open to participants now, 48 under way, 1 of them phase 3. Motor Activity · Germany.

Planned enrollment
45th of 193
213 · median 86
Started
2025
with 9 others
No phase
140 of 223
34 open now
Primary completion
2028-01
later than 41 of 47 live
Registered
209th of 223
by date
Lead sponsor
7 of 223
Heidelberg University

Among the 223 studies in Motor Activity with a site in Germany, this one is the 45th largest by planned enrollment of the 193 interventional ones that give a count, is one of 10 that started in 2025, is one of 140 with no phase, reaches primary completion later than 41 of the 47 other live ones, and was the 209th registered.

Motor Activity

9,827 studies on the registry are indexed under Motor Activity; 1,911 are open to participants now.

Browse Motor Activity studies →

Open to participants now

41 of the 223 studies in Motor Activity with a site in Germany are open now. Recruiting first, the newest first:

35 more — sign in →

All 41 open studies →

A study can be open while its sites in Germany have not opened yet or have stopped. Only those recruiting at a site in Germany →

Who these studies take

Of the 1,207 Motor Activity studies recruiting now, 524 (43%) set no upper age limit and 538 (45%) stop at 75 or younger; 180 take children under 18; 420 take healthy volunteers.

This study: 65 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 223 studies in Motor Activity with a site in Germany, or all of them as a file.
02

Study summary

The goal of this clinical trial is to evaluate the efficacy of a 12-week digital home-based intervention program, consisting of a tablet-based exercise program with or without personal coaching, to promote physical activity (PA) in older adults after total hip arthroplasty (THA). The main question it aims to answer is:

  • Does the combination of the digital exercise program and personal coaching lead to higher PA six months after THA compared to usual care among older adults?

Secondary questions are:

  • Does the digital exercise program alone lead to higher PA compared to usual care?
  • Does the digital exercise program combined with personal coaching lead to higher PA compared to the exercise program alone?

Participants' PA will be objectively measured with a body-fixed sensor at 1 week before THA (T1), 6 weeks after THA (T2), and 6 months (i.e. after THA (T3). After the postoperative assessment at T2, participants will be randomly assigned to one of three groups:

  • 12-week tablet-based exercise program at home with virtual personal coaching for physical activity promotion
  • 12-week tablet-based exercise program at home
  • Usual care (control group, no additional intervention)
Read the detailed description

Hip osteoarthritis is common in older adults and is associated with limitations in activities of daily living, mobility, and quality of life. THA effectively reduces pain and improves physical functioning. However, patients often show no or only minimal increase in their typically low preoperative PA after THA. This lack of PA improvements may result from short rehabilitation periods, persistent sedentary habits, and methodological limitations of PA monitoring methods that focus mainly on frequency or temporal parameters (e.g. step count, walking or active durations).

Digital home-based training programs offer an opportunity for patients to continue structured exercises independently and at flexible times, extending postoperative care beyond standard rehabilitation. In addition, personal coaching that applies behavioral change techniques (BCTs) such as goal setting, action planning, self-monitoring with feedback, and barrier identification and management, may help break sedentary habits and promote PA. Recent advances in wearable sensor technology and processing algorithms now also enable a more detailed monitoring of real-world digital mobility outcomes (DMOs), allowing also capturing spatial-related parameters (e.g., walking distance, stride length, gait speed).

The iPATH study is a three-armed, assessor-blinded, randomized, parallel-group clinical trial evaluating the efficacy of two 12-week digital home-based intervention programs to promote PA in 213 older adults after THA:

  1. Digital exercise program with personal coaching (Intervention Group 1)
  2. Digital exercise program without personal coaching (Intervention Group 2)
  3. Usual care (Control Group) - no additional intervention

Outcome assessments are conducted at 1 week preoperatively (T1), 6 weeks postoperatively (T2), and 6 months postoperatively (T3; operationally defined as 26 weeks after THA). Randomization occurs after the T2 assessment, which typically coincides with the end of standard inpatient or outpatient rehabilitation. The digital home-based exercise program in the two intervention arms is based on the Keep-On-Keep-Up (KOKU) app, which includes progressive strength and balance exercises to be performed three times per week. Personal coaching includes three virtual sessions designed to promote PA behavior change using BCTs (goal setting, action planning, self-monitoring and feedback [activity tracker], barrier identification and management). Participants in the control group also receive a tablet but have no access to the KOKU app and do not receive any personal coaching sessions.

The primary outcomes are the mean daily step count (first) and mean daily walking distance (second), derived from a body-fixed sensor attached to the participant's lower back for a maximum measurement period of 7 consecutive days using the newest validated processing alogorithms. Secondary outcomes include additional DMOs (e.g., walking duration, number of walking bouts, walking speed, stride length, cadence), life-space mobility, physical capacity, hip pain and function, psychological and cognitive factors (e.g., concerns about falling, executive functioning), falls, intervention adherence and acceptability, health-related resource use, intervention delivery costs, and safety.

The primary study hypothesis is that the combination of the digital exercise program and personal coaching will lead to higher PA six months after THA compared to usual care. Secondary hypotheses are that (1) the digital exercise program alone will increase PA compared to usual care, and (2) the combination of the digital exercise program and personal coaching will increase PA compared to the digital exercise program alone.

03

Conditions studied

  • Total Hip Arthroplasty (THA)
  • Older Adults (65 Years and Older)

Browse trials for

Keywords

  • Total Hip Arthroplasty
  • Physical Activity
  • Older Adults
  • Digital Intervention
  • Physical Exercise
  • Coaching
  • Patient Education
  • Postoperative Care
  • Ambulatory Monitoring
  • Behavior Change
04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age ≥65 years
  • Coxarthrosis with indication for total hip arthroplasty
  • Residence within a radius of ≤50 km from Heidelberg
  • Ability to walk ≥10 m (with/without walking aid)
  • Access to the internet (Wi-Fi) at home
  • Written

Exclusion criteria

Exclusion Criteria:

  • Insufficient German language skills
  • Insufficient hearing to communicate via (video) telephone
  • Insufficient vision to recognize study materials
  • Contralateral coxarthrosis with indication for total hip arthroplasty
  • Severe medical condition illnesses that compromise physical fitness (heart failure classified as [NYHA] class ≥3, heart valve defects associated with syncope, cardiac arrhythmia with dizziness, [COPD] with oxygen therapy, cancer with chemotherapy and/or radiation, Parkinson's disease with rollator use [Hoehn \& Yahr stage ≥4])
  • Living in a nursing home
  • Planned major medical procedure within the next 6 months with inpatient hospital stay (e.g., further surgery)
  • Simultaneous participation in another competing study
  • Cognitive impairment (6-item Cognitive Impairment Test [6CIT] score >7 points)
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

NYHA class (heart failure)

The New York Heart Association’s four classes of how much heart failure limits physical activity.

I
No limits: ordinary activity causes no undue tiredness or breathlessness.
II
Slight limits: comfortable at rest, ordinary activity causes symptoms.
III
Marked limits: comfortable at rest, less than ordinary activity causes symptoms.
IV
Symptoms even at rest; any activity makes them worse.

Studies set their own limit — many outside heart failure leave out class III–IV, while heart failure studies may ask for a particular class. Check the class this study names.

COPD

Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
213 participants (estimated)

Study arms

  • Experimental
    Digital exercise program with personal coaching (Intervention Group 1)

    Participants receive a tablet with the pre-installed training app KOKU, which delivers a 12-week standardized digital home-based strength and balance program. Participants are introduced to KOKU during an initial home visit and are encouraged to complete the program independently over the subsequent 12 weeks. In addition, they receive three individualized coaching sessions via video calls on the tablet during this period. To support self-monitoring and provide feedback on PA behavior - integrated into the BCTs used in the personal coaching - participants also receive a low-cost, easy-to-use wrist-worn activity tracker along with instructions on its use during the initial home visit.

    Behavioral: Digital exercise program · Behavioral: Personal coaching for physical activity promotion

  • Experimental
    Digital exercise program without personal coaching (Intervention Group 2)

    Participants receive a tablet with the pre-installed training app KOKU, which delivers a 12-week standardized digital home-based strength and balance program. Participants are introduced to KOKU during an initial home visit and are encouraged to complete the program independently over the subsequent 12 weeks. No personal coaching is provided.

    Behavioral: Digital exercise program

  • No intervention
    Usual care (Control Group)

    Participants receive a tablet without access to the KOKU app and do not receive any personal coaching sessions.

Interventions

  • BehavioralDigital exercise program

    KOKU is a digital adaptation of the evidence based Otago Exercise Program and Falls Management Exercise program, both designed to improve strength, balance, and reduce fall risk in older adults. KOKU includes 26 balance and strength exercises of varying difficulty. Each exercise is accompanied by written and audio instructions for safe performance and is demonstrated by a virtual trainer. Training sessions consist of three exercises suggested by the KOKU app, which participants are encouraged to perform for as many repetitions as possible until fatigue. Progression is guided by the participant's subjective assessment of effort and difficulty. Participants may choose to perform any exercise at any time, regardless of the app-suggested sequence. The KOKU app also provides reminders to exercise if no activity is detected for two days.

  • BehavioralPersonal coaching for physical activity promotion

    Personal coaching consists of three video calls conducted via the study tablet by staff trained in BCTs and motivational communication skills. Participants receive a low cost, wrist worn activity tracker during the initial home visit to support self-monitoring and provide feedback on PA behavior. The first virtual coaching session (week 2) focuses on goal setting and action planning, the second session (week 3) addresses identification and management of barriers, and the third session (week 12) serves as a booster to review and adjust activity goals for the post intervention period.

06

What researchers measure

Primary outcomes

  1. Daily step count

    Mean daily step count \[#/day\] is derived from a body-fixed sensor (AX6, Axivity Ltd.) attached to the participant's lower back for a maximum measurement period of 7 consecutive days, using validated processing algorithms.

    Time frame: 1 week preoperatively (T1), 6 weeks postoperatively (T2), and 6 months postoperatively (T3)

  2. Daily walking distance

    Mean daily cumulative walking distance \[m/day\] is derived from a body-fixed sensor (AX6, Axivity Ltd.) worn on the participant's lower back over a maximum measurement period of 7 consecutive days, based on validated processing algorithms.

    Time frame: 1 week preoperatively (T1), 6 weeks postoperatively (T2), and 6 months postoperatively (T3)

Secondary outcomes

  1. Daily walking duration

    Mean daily walking duration \[h/day\] derived from a body-fixed sensor (AX6, Axivity Ltd.) worn on the participant's lower back over a maximum measurement period of 7 consecutive days, based on validated processing algorithms.

    Time frame: 1 week preoperatively (T1), 6 weeks postoperatively (T2), and 6 months postoperatively (T3)

  2. Daily walking bout count

    Mean daily walking bout count \[#/day\] derived from a body-fixed sensor (AX6, Axivity Ltd.) worn on the participant's lower back over a maximum measurement period of 7 consecutive days, based on validated processing algorithms. Mean daily walking bout count is determined for walking bouts \>10 s, \>30 s, and \>60 s.

    Time frame: 1 week preoperatively (T1), 6 weeks postoperatively (T2), and 6 months postoperatively (T3)

  3. Daily-life walking bout duration

    Mean and 90th percentile daily-life walking bout durations \[s\] derived from a body-fixed sensor (AX6, Axivity Ltd.) worn on the participant's lower back over a maximum measurement period of 7 consecutive days, based on validated processing algorithms.

    Time frame: 1 week preoperatively (T1), 6 weeks postoperatively (T2), and 6 months postoperatively (T3)

  4. Daily-life walking speed

    Mean and 90th percentile daily-life walking speed \[m/s\] are derived from a body-fixed sensor (AX6, Axivity Ltd.) worn on the participant's lower back over a maximum measurement period of 7 consecutive days, based on validated processing algorithms. Mean and 90th percentile walking speeds are determined for shorter walking bouts (10-30 s) and for longer walking bouts (\>30 s).

    Time frame: 1 week preoperatively (T1), 6 weeks postoperatively (T2), and 6 months postoperatively (T3)

  5. Daily-life stride length

    Mean daily-life stride length \[cm\] is derived from a body-fixed sensor (AX6, Axivity Ltd.) worn on the participant's lower back over a maximum measurement period of 7 consecutive days, based on validated processing algorithms. Mean stride length is determined for shorter (10-30 s) and longer (\>30 s) walking bouts.

    Time frame: 1 week preoperatively (T1), 6 weeks postoperatively (T2), and 6 months postoperatively (T3)

  6. Daily-life stride duration

    Mean daily-life stride duration \[s\] derived from a body-fixed sensor (AX6, Axivity Ltd.) worn on the participant's lower back over a maximum measurement period of 7 consecutive days, based on validated processing algorithms. Mean stride duration is determined for all walking bouts and for longer walking bouts (\>30 s).

    Time frame: 1 week preoperatively (T1), 6 weeks postoperatively (T2), and 6 months postoperatively (T3)

  7. Daily-life cadence

    Mean and 90th percentile daily-life cadence \[steps/min\] derived from a body-fixed sensor (AX6, Axivity Ltd.) worn on the participant's lower back over a maximum measurement period of 7 consecutive days, based on validated processing algorithms. Mean cadence is determined for all walking bouts and for longer walking bouts (\>30 s), and the 90th percentile cadence for longer walking bouts (\>30 s).

    Time frame: 1 week preoperatively (T1), 6 weeks postoperatively (T2), and 6 months postoperatively (T3)

  8. Daily-life walking variability

    Bout-to-bout variability \[%\] in walking bout duration, walking speed and stride length for longer walking bouts (\>30 s), cadence and stride duration for all walking bouts, derived from a body-fixed sensor (AX6, Axivity Ltd.) worn on the participant's lower back over a maximum of 7 consecutive days, based on validated processing algorithms.

    Time frame: 1 week preoperatively (T1), 6 weeks postoperatively (T2), and 6 months postoperatively (T3)

  9. Physical capacity (a)

    6-Minute Walk Test (instrumented with the mTEST³ system \[mHealth Technologies srl, Bologna, Italy\] to capture spatio-temporal gait parameters)

    Time frame: 1 week preoperatively (T1), 6 weeks postoperatively (T2), and 6 months postoperatively (T3)

  10. Physical capacity (b)

    Timed Up and Go (instrumented with the mTEST³ system \[mHealth Technologies srl, Bologna, Italy\] to measure durations of sit-to-walk, walking, turning, and sitting segments)

    Time frame: 1 week preoperatively (T1), 6 weeks postoperatively (T2), and 6 months postoperatively (T3)

  11. Physical capacity (c)

    30-Second Chair Stand Test

    Time frame: 1 week preoperatively (T1), 6 weeks postoperatively (T2), and 6 months postoperatively (T3)

  12. Physical capacity (d)

    4-Meter Gait Speed Test

    Time frame: 1 week preoperatively (T1), 6 weeks postoperatively (T2), and 6 months postoperatively (T3)

  13. Hip pain and function

    Oxford Hip Score

    Time frame: 1 week preoperatively (T1), 6 weeks postoperatively (T2), and 6 months postoperatively (T3)

  14. Life-space mobility

    University of Alabama at Birmingham Life-Space Assessment

    Time frame: 1 week preoperatively (T1), and 6 months postoperatively (T3)

  15. Concerns about falling

    Short Falls Efficacy Scale-International

    Time frame: 1 week preoperatively (T1), 6 weeks postoperatively (T2), and 6 months postoperatively (T3)

  16. Health-related quality of life

    European Quality of Life 5 Dimensions 5 Level index

    Time frame: 1 week preoperatively (T1) and 6 months postoperatively (T3)

  17. Self-perceived health status

    EuroQol Visual Analogue Scale

    Time frame: 1 week preoperatively (T1) and 6 months postoperatively (T3)

  18. Change in self-perceived walking ability

    7-point Global Rating of Change Scale (1= markedly worse, 7 = markedly better)

    Time frame: 6 weeks postoperatively (T2) and 6 months postoperatively (T3)

  19. Self-reported physical activity level

    University of California Los Angeles Activity Score

    Time frame: 1 week preoperatively (T1) and 6 months postoperatively (T3)

  20. Conscientiousness

    Conscientiousness dimension of Big Five Inventory-2

    Time frame: 1 week preoperatively (T1), 6 weeks postoperatively (T2), and 6 months postoperatively (T3)

  21. Exercise motivation

    Behavioural Regulation in Exercise Questionnaire

    Time frame: 1 week preoperatively (T1), 6 weeks postoperatively (T2), and 6 months postoperatively (T3)

  22. Rate of falls

    Daily fall calendars

    Time frame: From 6 weeks postoperatively (T2) to 6 months postoperatively (T3)

  23. Executive functioning

    Trail Making Test A \& B

    Time frame: 1 week preoperatively (T1) and 6 months postoperatively (T3)

  24. Health-related resource use

    Questionnaire for Health-Related Resource Use in an Elderly Population

    Time frame: 1 week preoperatively (T1) and 6 months postoperatively (T3)

Other outcomes

  1. Adverse events

    Frequency, type, severity, and relation to the intervention of participant-reported (serious) adverse adverse events will be documented using standardized case report forms.

    Time frame: 6 weeks postoperatively (T2) and 6 months postoperatively (T3); interim events recorded as reported.

  2. Training adherence (a)

    Exercise Adherence Rating Scale

    Time frame: 6 months postoperatively (T3)

  3. Training adherence (b)

    Usage data of the training app (KOKU) retrieved from the tablet

    Time frame: 6 months postoperatively (T3)

  4. Intervention acceptability (a)

    Theoretical Framework of Acceptability Questionnaire (range: 7-35 points, higher scores indicate higher acceptability)

    Time frame: 6 months postoperatively (T3)

  5. Intervention acceptability (b)

    5-point Likert scale on global acceptability (1 = completely unacceptable, unacceptable, 5 = completely acceptable)

    Time frame: 6 months postoperatively (T3)

  6. Intervention delivery costs

    Intervention costs \[€\] derived from personnel, material, and travel expenses, using standardized national unit costs.

    Time frame: From the start of the intervention to the end of the intervention (up to 12 weeks)

07

Study locations

1 of 1 sites recruiting
  • Department of Orthopaedics, Heidelberg University Hospital
    Heidelberg, Baden-Wurttemberg 69118, Germany
    Recruiting
08

References and documents

Publications

  • Buchner T, Knopf S, Haas AS, Eckert T, Fritz R, Merling M, Sander A, Klose C, Walker T, Bauer JM, Becker C, Werner C, Reiner T. Digital home-based physical activity promotion for older adults after total hip arthroplasty: protocol for the randomized controlled iPATH trial. BMC Geriatr. 2026 Jan 24;26(1):102. doi: 10.1186/s12877-026-07013-9. PubMed 41578219 ↗

Individual participant data

Plan to share: Yes — In line with the principles of open science, anonymized individual participant data from the iPATH trial will be made available to qualified researchers after the primary evaluation has been completed and published. Data will be shared in a format that does not permit identification of individual participants and in full compliance with applicable data protection regulations (e.g., General Data Protection Regulation, EU data protection standards). Access to the data will be provided via a recognized open-access repository and require a formal application with a description of the proposed research project.

Supporting information: Study protocol, Statistical analysis plan

Time frame: Anonymized individual participant data (IPD) will be made available approximately 6 months after publication of the primary evaluation results and will remain accessible without a predefined end date. The study protocol will be submitted for publication in an open-access, peer-reviewed journal before the last patient is enrolled. The statistical analysis plan (SAP) will be published alongside the primary evaluation results.

Access criteria: Access will be granted to qualified researchers affiliated with recognized academic or research institutions. A formal application including a research proposal is required, and applicants must agree to a data use agreement ensuring ethical use and compliance with EU data protection regulations. Approved applicants will access the data via the designated open-access repository.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Sep 2025; primary completion for Jan 2028, 28 months later.

Of 5,176 non-industry interventional studies with no phase under Motor Activity, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 36. This study's planned 28 months is above that.

Counting every sponsor, half of 5,236 studies reached it within 17 months; a quarter within 7 and three quarters within 36.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 7, 2025
First posted
Aug 22, 2025
StartEst.
Sep 2025
Primary completionEst.
Jan 2028
CompletionEst.
Jan 2028
Last update
Sep 2, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 2, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07135843
Responsible party
Tobias Reiner (Priv.-Doz. Dr. med., University Hospital Heidelberg) — Principal investigator
First posted
Aug 22, 2025
Start date
Sep 2025 (estimated)
Primary completion
Jan 2028 (estimated)
Completion
Jan 2028 (estimated)
Last update
Sep 2, 2025

Study contacts

Tobias Eckert, PhD
Contact
tobias.eckert@med.uni-heidelberg.de
+49 (0)6221 319 1562
Christian Werner, PhD
Contact
christian.werner@med.uni-heidelberg.de
+49 (0)6221 319 1759
Tobias Reiner, PhD, MD
principal investigator · Department of Orthopaedics, Heidelberg University Hospital
Christian Werner, PhD
principal investigator · Heidelberg University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion